KKR-Backed Clinical Trials Co. Sets Terms For $400M IPO
Private equity-backed clinical trials company PRA Health Sciences Inc. set terms on Monday to raise $400 million in its initial public offering as it aims to pay down debt and potentially...To view the full article, register now.
Already a subscriber? Click here to view full article